- Home
- RGNX vs PFL Comparison
RGNX vs PFL Comparison
Compare RGNX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- PFL
- Stock Information
- Founded
- RGNX 2008
- PFL 2003
- Country
- RGNX United States
- PFL United States
- Employees
- RGNX N/A
- PFL N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- PFL Finance Companies
- Sector
- RGNX Health Care
- PFL Finance
- Exchange
- RGNX Nasdaq
- PFL Nasdaq
- Market Cap
- RGNX 424.8M
- PFL 374.5M
- IPO Year
- RGNX 2015
- PFL N/A
- Fundamental
- Price
- RGNX $8.17
- PFL $8.53
- Analyst Decision
- RGNX Strong Buy
- PFL
- Analyst Count
- RGNX 8
- PFL 0
- Target Price
- RGNX $31.75
- PFL N/A
- AVG Volume (30 Days)
- RGNX 542.3K
- PFL 113.7K
- Earning Date
- RGNX 08-07-2025
- PFL 01-01-0001
- Dividend Yield
- RGNX N/A
- PFL 11.53%
- EPS Growth
- RGNX N/A
- PFL N/A
- EPS
- RGNX N/A
- PFL N/A
- Revenue
- RGNX $156,718,000.00
- PFL N/A
- Revenue This Year
- RGNX $327.08
- PFL N/A
- Revenue Next Year
- RGNX N/A
- PFL N/A
- P/E Ratio
- RGNX N/A
- PFL N/A
- Revenue Growth
- RGNX 80.70
- PFL N/A
- 52 Week Low
- RGNX $5.04
- PFL $6.98
- 52 Week High
- RGNX $13.48
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- RGNX 45.17
- PFL 76.24
- Support Level
- RGNX $8.27
- PFL $8.31
- Resistance Level
- RGNX $9.32
- PFL $8.55
- Average True Range (ATR)
- RGNX 0.49
- PFL 0.05
- MACD
- RGNX -0.04
- PFL 0.02
- Stochastic Oscillator
- RGNX 20.16
- PFL 93.33
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.